{"organizations": [], "uuid": "0a202f1798e97167179affc80d9c67b7e9a6e7ab", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.bio-medicine.org", "main_image": "", "site_section": "http://www.bio-medicine.org/inc/biomed/medicine-technology.asp", "section_title": "Latest Medical Technology from Bio-Medicine.Org", "url": "http://www.bio-medicine.org/medicine-technology-1/Essentialis-Announces-the-Dosing-of-the-First-Prader-Willi-Syndrome-Patients-in-a-Long-Term-Extension-to-Clinical-Trial-PC025-48132-1/", "country": "US", "title": "Essentialis Announces the Dosing of the First Prader-Willi Syndrome Patients in a Long-Term Extension to Clinical Trial PC025", "performance_score": 0, "site": "bio-medicine.org", "participants_count": 0, "title_full": "Essentialis Announces the Dosing of the First Prader-Willi Syndrome Patients in a Long-Term Extension to Clinical Trial PC025", "spam_score": 0.0, "site_type": "news", "published": "2015-09-09T14:08:00.000+03:00", "replies_count": 0, "uuid": "0a202f1798e97167179affc80d9c67b7e9a6e7ab"}, "author": "", "url": "http://www.bio-medicine.org/medicine-technology-1/Essentialis-Announces-the-Dosing-of-the-First-Prader-Willi-Syndrome-Patients-in-a-Long-Term-Extension-to-Clinical-Trial-PC025-48132-1/", "ord_in_thread": 0, "title": "Essentialis Announces the Dosing of the First Prader-Willi Syndrome Patients in a Long-Term Extension to Clinical Trial PC025", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "... ... ... ... ... ... ... ... ... ... Orexigen(R) Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) arGEN-X SIMPLE Antibody(TM) Platform set to Transform Therapeutic Antibody Discovery & Development  ", "external_links": [], "published": "2015-09-09T14:08:00.000+03:00", "crawled": "2015-09-09T14:35:08.257+03:00", "highlightTitle": ""}